Clinical Trial Update: Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMD [NA]

View source ↗

Summary

A clinical trial comparing intravitreal bevacizumab versus combination therapy for choroidal neovascularization due to conditions other than age-related macular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioid Streaks
• Central Serous Chorioretinopathy
• Choroidal Neovascularization
• Multifocal Choroiditis
• Myopia
• Ocular Histoplasmosis Syndrome
• Punctate Inner Choroidopathy
• Trauma or Hereditary Eye Diseases

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Choroidal Neovascularization, Myopia | NA | Status: WITHDRAWN